Platelet-Rich Plasma Treatment for Accelerated Androgenetic Alopecia Pattern Hair Loss After COVID-19 Infection: A Case Series.

Abstract

Hair-related manifestations such as alopecia areata or telogen effluvium were reported during COVID-19 disease. Accelerated hair loss with androgenetic alopecia (AGA) pattern or management has not been discussed before. This study aimed to examine the accelerated AGA pattern hair loss and management with PRP treatment. This study was designed prospectively and nine patients included to study confirmed PCR test for COVID-19 infection. Patients underwent platelet-rich plasma (PRP) injections for 4sessions. Results were accessed with the hair pull test (HPT) and self-administered hair growth questionnaire (HGQ). Nine patients were admitted with complaints of hair loss after an average of 220±24.2 (min: 182max: 264) day after recovery of COVID-19. Mean age of the patients was 33.8±8.4years old (min: 26, max: 52). Six (66.7%) patients were male, and three (33.3%) of them were female. HPT score decreased to 6.0±1.6 after the first PRP application (p=0.007, CI 95%:2.7-5.2) and decreased to 1.2±0.8 after the last PRP session (p=0.008, CI 95%: 6.4-11.1). Five (55.5%) of the patients described the treatment as "very effective" after treatment with HGQ. Accelerated hair loss associated with COVID-19 continues in long term and PRP treatment provides a satisfactory solution.